signal/raiseTrack rounds

B

Bain Capital Life Sciences

Focus: Healthtech & bio

Bain Capital Life Sciences took part in 2 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $310m. By money raised, its biggest sector was Healthtech & bio. The largest was AdvanCell's $315m Series D+ round. The most recent was OMass Therapeutics's Series C round in October 2026.

Deployed as lead$310m

Rounds led1

Rounds joined2

Largest round$315m

Rounds led (1)

OMass TherapeuticsSeries C · Healthtech & bio · Oxford · 15 Oct$310m

Also invested (1)

AdvanCellSeries D+ · Healthtech & bio · Brisbane · 15 Jul$315m

By sector

Healthtech & bio$625m

By stage

Series C$310m Series D+$315m

Co-investors

SV Health Investors2 rounds Sanofi Ventures2 rounds Janus Henderson Investors1 round Oxford Science Enterprises1 round GV1 round British Business Bank1 round University of Oxford1 round Alpha Wave1 round Fidelity1 round T. Rowe Price1 round